Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-03-07
1995-11-14
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 64, 536 2853, 424 111, A61K 3170, A61K 3322, C07H 1906, C07H 2300
Patent
active
054666791
ABSTRACT:
The invention relates to novel boron-containing nucleosides and amino acids which can utilize the enzymatic systems in tumor cells for incorporating such boron-containing structures into nucleic acids and proteins. Subsequent use of boron neutron capture therapy provides a method for treating tumor cells.
REFERENCES:
patent: 5130302 (1992-07-01), Spielvogel et al.
patent: 5171849 (1992-12-01), Soloway et al.
patent: 5260427 (1993-11-01), Spielvogel et al.
patent: 5362732 (1994-11-01), Spielvogel et al.
patent: 5399732 (1995-03-01), Spielvogel et al.
Mishima et al., The J. of Investigative Dermatology, vol. 92, No. 5, Supplement, pp. 321S-325S, (1989).
Barth et al., Cancer, vol. 70, No. 12, "Boron Neutron Capture Therapy for Cancer," pp. 2995-3008 (1992).
Barth et al., Cancer Research, vol. 50, "Boron Neutron Capture Therapy of Cancer," pp. 1061-1070, (1990).
Barth et al., Scientific American, vol. 262, No. 10, "Boron Neutron Capture Therapy for Cancer," pp. 100-105, (1990).
Schinazi et al., "Boron Compound Suitable for Neutron Capture Therapy for . . . Cancer", National Cancer Institute Workshop, May 3-4, 1988.
Kabalka et al., "Boron-11 MRI and MRS of Intact Animals Infused with a Boron Neutron Capture Agent," Magnetic Resonance in Medicine V. 8, p. 231, (1988).
Schinazi et al., "Rational Design of Pyrimidines and Nucleosides for Neutron Capture Therapy," National Cancer Institute Workshop, pp. 1-11, (1988).
Yamamoto et al., J. Chem. Soc, Chem, Commun., pp. 157-158 (1992).
Wyzlic et al., Tetrahedron Letters, vol. 33, No. 49, pp. 7489-7490 (1992).
Tjarks et al., 5th Intl. Symposium on NCT for Cancer, Sep. 1992.
Anisuzzaman Abul K.
Barth Rolf F.
Rong Feng-Guang
Soloway Albert H.
Tjarks Werner
Foster Frank H.
Robinson Douglas W.
The Ohio State University Research Foundation
Wilson James O.
LandOfFree
Carboranyl uridines and their use in boron neutron capture thera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboranyl uridines and their use in boron neutron capture thera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboranyl uridines and their use in boron neutron capture thera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1221014